About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

A Phase I Study of Pazopanib in Adult Patients With Liver Cancer

NCT00370513·3 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

GlaxoSmithKline

Age

21–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Diagnosis of advanced liver cancer adequate bone marrow, liver and kidney function
Any local therapy for tumor must have been completed at least 4 weeks prior to enrolling in study

You may not be if

Pregnant or breastfeeding
Any serious or unstable medical or psychiatric conditions
History of metastases to central nervous system
History of ulcer, inflammatory bowel disease or disease of the gut
History of HIV, or uncontrolled infection
Have had a cardiac condition or stoke during the past 6 months
High blood pressure
Have had a blood clot during the past 6 months
History of bleeding blood vessels

The record

StatusCompleted

PhasePhase 1

Taking part28

StartedDec 2006

UpdatedNov 17, 2017

Conditions

Carcinoma, Hepatocellular

Where3

GSK Investigational Site
San Francisco, California, United States
GSK Investigational Site
Hong Kong, Hong Kong
GSK Investigational Site
Taipei, Taiwan

Clareo Health | A Phase I Study of Pazopanib in Adult Patients With Liver Cancer